Wyriclav™ 228.5 Dry Syrup is a broad-spectrum beta-lactam antibiotic combination formulated for effective management of bacterial infections in paediatric patients. It combines Amoxycillin, a penicillin-class antibiotic, with Potassium Clavulanate, a beta-lactamase inhibitor that protects Amoxycillin from enzymatic degradation, thereby extending its antibacterial spectrum.
This formulation is supplied as a dry syrup with sterile water for reconstitution, ensuring accurate dosing, better stability, and improved palatability for children.
Composition (After Reconstitution):
Each 5 ml contains:
-
Amoxycillin Trihydrate I.P.
Equivalent to Amoxycillin 200 mg -
Potassium Clavulanate Diluted I.P.
Equivalent to Clavulanic Acid 28.5 mg -
Excipients q.s.
Mechanism of Action:
-
Amoxycillin inhibits bacterial cell wall synthesis, leading to bacterial cell death.
-
Clavulanic Acid inhibits beta-lactamase enzymes produced by resistant bacteria, restoring the activity of Amoxycillin.
Indications / Uses:
-
Upper & lower respiratory tract infections
-
Ear, nose & throat infections
-
Skin and soft tissue infections
-
Urinary tract infections
-
Dental infections
-
Other susceptible bacterial infections as prescribed
Direction for Reconstitution:
-
Shake the bottle to loosen the powder
-
Add sterile water in two stages up to the mark
-
Shake well after each addition
-
Shake well before every use
Dosage & Administration:
-
Dosage as directed by the Physician
-
For paediatric use only
Storage:
-
Store unreconstituted powder in a cool, dry place
-
After reconstitution, store in a refrigerator
-
Use within the prescribed period after reconstitution
-
Do not freeze
Warnings & Precautions:
-
Schedule H Prescription Drug
-
Not to be sold without prescription of a Registered Medical Practitioner
-
Complete the full course of treatment
Pack Details:
-
Strength: 228.5 mg/5 ml
-
Dosage Form: Dry Syrup
-
Pack Size: 3 g / 30 ml
-
Route: Oral
-
Flavour: Orange
Reviews
There are no reviews yet.